Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/2015

01-04-2015 | Erratum

Erratum to: Heterosexual couples and prostate cancer support groups: a gender relations analysis

Authors: John L. Oliffe, Lawrence W. Mróz, Joan L. Bottorff, Debbie E. Braybrook, Amanda Ward, S. Larry Goldenberg

Published in: Supportive Care in Cancer | Issue 4/2015

Login to get access

Excerpt

Erratum to: Support Care Cancer …
Metadata
Title
Erratum to: Heterosexual couples and prostate cancer support groups: a gender relations analysis
Authors
John L. Oliffe
Lawrence W. Mróz
Joan L. Bottorff
Debbie E. Braybrook
Amanda Ward
S. Larry Goldenberg
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2600-5

Other articles of this Issue 4/2015

Supportive Care in Cancer 4/2015 Go to the issue

Original Article

Dietary habits changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer

Original Article

Identifying clinical and support service resources and network practices for cancer patients and survivors in southern Puerto Rico

Letter to the editor

Author response to “Scientific rigour is far more than a matter of sample size”

Letter to the editor

Scientific rigour is far more than a matter of sample size

Original Article

Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy

Original Article

A mindfulness-based program for improving quality of life among hematopoietic stem cell transplantation survivors: feasibility and preliminary findings
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits